The HPV Test: Coming Soon to a Doctor’s Office Near You? Is It Better than the Pap Smear for Detecting Cervical Cancer? – Agenda

Are Schools Just Saying No

The HPV Test: Coming Soon To A Doctor s Office Near You?

Is It Better Than the Pap Smear for Detecting Cervical Cancer?

Thursday, February 17, 9:30 – 11:30 a.m.

Broadway Millennium Hotel

44th and Broadway, New York City

9:30 a.m.Registration

9:50 a.m.Welcome/Introductions

    • Tina Hoff, Director of Public Health Information and Communications, Kaiser Family Foundation, will provide an overview of the most common sexually transmitted disease in the U.S. — HPV (human papillomavirus) — and present findings of how much the American public knows about it.

10:00 a.m.Understanding The Latest Medical Research: What is the New Data on HPV Testing and Cervical Cancer, and What Does it Mean for American Women?

    • Mark Schiffman, MD, MPH, Chief of the Interdisciplinary Study Section, Division of Cancer Epidemiology and Genetics, National Cancer Institute
    • Thomas C. Wright, Jr., MD, Director of Gynecologic Pathology, Dept. of Pathology, Columbia University College of Physicians and Surgeons

These leading experts in the field of cancer research, published in the January 2000 issue of the Journal of the American Medical Association, will detail recent findings from their two studies on the use of the HPV DNA test to screen for cervical cancer. They will discuss what impact these findings may have for American women, particularly those most at risk for cervical cancer, as well as whether the HPV test is a better alternative to the Pap smear.

10:45 a.m.From Research to the Real World:

    • J. Thomas Cox, Executive Medical Director, American Social Health Association, National HPV and Cervical Cancer Resource Center, and Director, Student Health Services GYN Clinic, University of California at Santa Barbara, will describe the public education challenges presented by HPV, in particular what sexually active people can do to prevent transmission of the sexually transmitted disease.

    • Robin Richman, MD, FACOG, Vice President and Medical Director of Quality Improvement/Women’s Health, Tufts Health Plan, and Chair of the American Association of Health Plans Women’s Health Task Force
    • , will talk about the health insurance industry s response to advances in screening techniques, in terms of covering test costs and concerns about women obtaining medical insurance if they have a pre-existing condition such as HPV.

11:15 a.m.Questions and Answers

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.